BECLIN-1 deficiency has been characterized in several pathological conditions and enhancing autophagy, for example with the Tat-BECLIN-1 construct, has been presented as a potential route for valuable therapeutic applications, notably in neurodegenerative diseases (63, 73, 74). This evidence concerns the gene BECN1 and neurodegenerative disease.